Biomarkers for Ventilator-associated Pneumonia

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06370598` - Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia	Phase 1/Phase 2
Terminated	`NCT02806141` - Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates	Phase 3
Completed	`NCT01765530` - Efficacy Study of a Novel Device to Clean the Endotracheal Tube	N/A
Completed	`NCT00521677` - Comparison Between Two Methods of Oral Care on the Incidence of VAP	N/A
Completed	`NCT00529776` - Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy	N/A
Completed	`NCT03401463` - Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar	N/A
Completed	`NCT02950519` - Endotracheal Tube Cuff Pressures in Ventilated Patients	N/A
Completed	`NCT01875692` - Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?	N/A
Completed	`NCT00515034` - A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia	Phase 2
Completed	`NCT04755972` - Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2	N/A
Terminated	`NCT02940626` - Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.	Phase 2
Completed	`NCT01577862` - Colistin and Rifampicin for MDR-Acinetobacter	Phase 3
Completed	`NCT00572559` - Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus	Phase 4
Withdrawn	`NCT04566172` - Preoperative Optimization to Improve Functional Status	N/A
Recruiting	`NCT04215692` - Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients	N/A
Completed	`NCT03816956` - Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301	Phase 3
Active, not recruiting	`NCT01123681` - Intubation and Extubation Over 48 Hours Mechanical Ventilation	N/A
Recruiting	`NCT04839653` - Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria	N/A
Recruiting	`NCT03527992` - Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia	N/A
Recruiting	`NCT05405491` - Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation	N/A

NCT number	NCT05117125
Study type	Observational
Source	Region Skane
Contact	Magnus Paulsson, PhD MD
Phone	+46461775431
Email	magnus.paulsson@med.lu.se
Status	Recruiting
Phase
Start date	October 15, 2021
Completion date	December 31, 2026

Biomarkers for Ventilator-associated Pneumonia — VAPmarkers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms